Latest News and Press Releases

Chemomab reported positive topline results from Ph 2 trial assessing CM-101 in PSC. Achieved safety endpoint and improved wide range of secondary endpoints

New publication confirms the role of CCL24 in primary sclerosing cholangitis and the potential of CM-101 to impact PSC disease progression and severity.

Blair, Nebraska, April 10, 2024 (GLOBE NEWSWIRE) -- Great Plains Communications (GPC), the Midwestern digital infrastructure provider with a growing, privately owned 18,000+ mile fiber network...

Chemomab's KOL primary sclerosing cholangitis virtual event on April 10 at 10:00 AM ET will include physician & patient PSC experts & a live Q&A session.

NEWCASTLE UPON TYNE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- PSC Consulting is pleased to announce the appointment of James Drummond as Managing Director of its European operations. The...

GUILFORD, Conn., April 26, 2023 (GLOBE NEWSWIRE) -- Invea Therapeutics (Invea), a biotechnology company developing an artificial intelligence (AI) and machine learning (ML) powered pipeline of...

BELFIELD, N.D., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Energy Group, Inc., the leading innovator in the petroleum refining industry, announced today that the North Dakota Supreme Court ruled in...

BELFIELD, N.D., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Meridian Energy Group, Inc., the leading developer of innovative and environmentally-compliant oil refining facilities, announced today that a...

HOUSTON, TX--(Marketwire - Nov 16, 2011) - ERHC Energy Inc. (OTCBB: ERHE), a publicly traded American company with oil and gas assets in Sub-Saharan Africa, today announced the commencement of...

HOUSTON, TX--(Marketwire - Aug 23, 2011) - ERHC Energy Inc. (OTCBB: ERHE), a publicly traded American company with oil and gas assets in West and Sub-Saharan Africa, today announced that the...